MYAM
WST icon

Meiji Yasuda Asset Management’s West Pharmaceutical WST Stock Holding History

Meiji Yasuda Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.63M Sell
12,910
-1,091
-8% -$334K 0.21% 144
2026
Q1 		$3.51M Buy
14,001
+3,006
+27% +$748K 0.18% 156
2025
Q4 		$3.03M Buy
10,995
+182
+2% +$49.8K 0.15% 175
2025
Q3 		$2.84M Buy
10,813
+1,250
+13% +$304K 0.14% 180
2025
Q2 		$2.09M Sell
9,563
-685
-7% -$146K 0.1% 200
2025
Q1 		$2.29M Sell
10,248
-737
-7% -$203K 0.09% 221
2024
Q4 		$3.6M Buy
10,985
+7,744
+239% +$2.44M 0.14% 168
2024
Q3 		$973K Sell
3,241
-5,266
-62% -$1.61M 0.04% 312
2024
Q2 		$2.8M Buy
8,507
+278
+3% +$98.2K 0.11% 184
2024
Q1 		$3.26M Sell
8,229
-2,070
-20% -$766K 0.14% 173
2023
Q4 		$3.63M Buy
10,299
+5,135
+99% +$1.82M 0.16% 166
2023
Q3 		$1.94M Buy
5,164
+218
+4% +$84.3K 0.09% 238
2023
Q2 		$1.89M Sell
4,946
-336
-6% -$120K 0.09% 215
2023
Q1 		$1.83M Buy
5,282
+1,417
+37% +$414K 0.09% 217
2022
Q4 		$910K Buy
3,865
+574
+17% +$136K 0.04% 330
2022
Q3 		$810K Buy
3,291
+488
+17% +$149K 0.05% 332
2022
Q2 		$848K Buy
2,803
+145
+5% +$47.2K 0.05% 355
2022
Q1 		$1.09M Buy
2,658
+273
+11% +$107K 0.06% 311
2021
Q4 		$1.12M Buy
2,385
+58
+2% +$25K 0.07% 254
2021
Q3 		$988K Buy
2,327
+182
+8% +$76.7K 0.07% 257
2021
Q2 		$770K Buy
2,145
+1,230
+134% +$406K 0.04% 304
2021
Q1 		$258K Buy
915
+110
+14% +$31.5K 0.02% 459
2020
Q4 		$228K Sell
805
-15
-2% -$4.21K 0.02% 383
2020
Q3 		$225K Sell
820
-140
-15% -$37K 0.02% 349
2020
Q2 		$218K Buy
+960
New +$189K 0.02% 445

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Meiji Yasuda Asset Management's WST Position: Q2 2026 in Review

Meiji Yasuda Asset Management reduced its West Pharmaceutical (WST) stake by 7.8% in Q2 2026, selling an estimated $334K and leaving 12,910 shares worth $4.63M. The position accounts for 0.21% of the portfolio, ranked #144.

Meiji Yasuda Asset Management first reported a position in WST in Q2 2020 and has held it in 25 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Meiji Yasuda Asset Management held 12,910 shares of West Pharmaceutical worth $4.63M as of Q2 2026.
  • Meiji Yasuda Asset Management sold 1,091 West Pharmaceutical shares in Q2 2026, an estimated $334K.
  • West Pharmaceutical made up 0.21% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #144 holding.
  • Meiji Yasuda Asset Management first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.